Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Nephros ( (NEPH) ) has issued an announcement.
On April 23, 2025, Alisa Lask informed Nephros, Inc. that she will not seek re-election to the Board of Directors at the upcoming annual stockholders meeting on June 16, 2025. Her decision is not due to any disagreements with the company’s operations or policies.
Spark’s Take on NEPH Stock
According to Spark, TipRanks’ AI Analyst, NEPH is a Neutral.
Nephros shows strengths in financial stability and technical momentum, supported by strategic leadership initiatives. However, the extremely high P/E ratio indicates potential overvaluation, and challenges in revenue consistency and cash flow generation remain key concerns.
To see Spark’s full report on NEPH stock, click here.
More about Nephros
YTD Price Performance: 37.67%
Average Trading Volume: 14,717
Technical Sentiment Signal: Sell
Current Market Cap: $21.31M
Learn more about NEPH stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue